EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Salvage Yttrium-90 Transarterial Radioembolization Combined with Second-Line Molecular Targeted Agents and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Progressing After TACE-Based Combination Therapy: A Single-Center Real-World Study

Wenchang Yu, Weifu Liu, Mingzhi Hao iD, Yubin Hu iD, Zhuting Fang

Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-15

DOI: 10.2147/jhc.s638164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Wenchang Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 35…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ALBI scorehepatocellular carcinomaimmune checkpoint inhibitorsmolecular targeted agentssalvage therapyyttrium-90 transarterial radioembolization

Autor:innen und Institutionen

  • Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, People's Republic of China.
  • Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, People's Republic of China.

ORCID-Profile: Mingzhi Hao, Yubin Hu

Zitieren

APA

Yu, W., Liu, W., Hao, M., Hu, Y., & Fang, Z. (2026). Salvage Yttrium-90 Transarterial Radioembolization Combined with Second-Line Molecular Targeted Agents and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Progressing After TACE-Based Combination Therapy: A Single-Center Real-World Study. Journal of Hepatocellular Carcinoma, Volume 13, 1-15. https://doi.org/10.2147/jhc.s638164

Vancouver

Yu W, Liu W, Hao M, Hu Y, Fang Z. Salvage Yttrium-90 Transarterial Radioembolization Combined with Second-Line Molecular Targeted Agents and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Progressing After TACE-Based Combination Therapy: A Single-Center Real-World Study. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-15. doi:10.2147/jhc.s638164

BibTeX
@article{Yu2026,
  author = {Yu, Wenchang and Liu, Weifu and Hao, Mingzhi and Hu, Yubin and Fang, Zhuting},
  title = {Salvage Yttrium-90 Transarterial Radioembolization Combined with Second-Line Molecular Targeted Agents and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Progressing After TACE-Based Combination Therapy: A Single-Center Real-World Study},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--15},
  doi = {10.2147/jhc.s638164}
}
Kostenlos starten →